Cargando…

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies

Myeloid-derived suppressor cells (MDSCs) are immature myeloid precursors which emerged as a potent regulator of the immune system, exerting suppressive properties in diverse disease settings. In regards to cancer, MDSCs have an established role in solid tumors; however, their contribution to immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papafragkos, Iosif, Markaki, Efrosyni, Kalpadakis, Christina, Verginis, Panayotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397155/ https://www.ncbi.nlm.nih.gov/pubmed/34441758 http://dx.doi.org/10.3390/jcm10163462

Ejemplares similares

Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
por: Papafragkos, Iosif, et al.
Publicado: (2022)

Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle
por: Hatzioannou, Aikaterini, et al.
Publicado: (2021)

Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells
por: Vetro, Calogero, et al.
Publicado: (2015)

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
por: Kapor, Suncica, et al.
Publicado: (2021)

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
por: Lv, Meng, et al.
Publicado: (2019)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
por: Yu, Shunjie, et al.
Publicado: (2022)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
por: Wang, Shifen, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
por: Bhardwaj, Vaishali, et al.
Publicado: (2023)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
por: Bryant, Andrew J., et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells in Solid Tumors
por: Ma, Tianmiao, et al.
Publicado: (2022)

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
por: Veglia, Filippo, et al.
Publicado: (2021)

Investigating the role of “Immature Myeloid Cells” as Drivers of Inflammation and Disease Persistence in Psoriatic Arthritis
por: Grivas, Alexandros, et al.
Publicado: (2023)

Decoding of translation‐regulating entities reveals heterogeneous translation deficiency patterns in cellular senescence
por: Papaspyropoulos, Angelos, et al.
Publicado: (2023)

DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity
por: Manolakou, Theodora, et al.
Publicado: (2021)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

The role of myeloid‐derived suppressor cells in gastrointestinal cancer
por: Cui, Cheng, et al.
Publicado: (2021)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells for cancer therapy
por: Tang, Hongchao, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
por: Kim, Yeon-Jeong, et al.
Publicado: (2015)

Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells
por: Damuzzo, Vera, et al.
Publicado: (2015)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

The role of myeloid-derived suppressor cells in liver cancer
por: Zhou, Shiyue, et al.
Publicado: (2023)

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
por: Parrondo, Ricardo D., et al.
Publicado: (2023)

Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy
por: Zhang, Weitao, et al.
Publicado: (2018)

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
por: Tian, Xinyu, et al.
Publicado: (2019)

P1270: IMMUNE REGULATORY CELLS IN B-CELL LYMPHOMAS: SIGNIFICANT HETEROGENEITY ACROSS HISTOLOGIC TYPES.
por: STAVROULAKI, M., et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
por: Katoh, Hiroshi, et al.
Publicado: (2015)

The emerging role of myeloid-derived suppressor cells in radiotherapy
por: Kang, Changhee, et al.
Publicado: (2020)

P752: TRANSCRIPTOMIC ANALYSIS OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
por: Bizymi, Nikoleta, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma
por: Pang, Xin, et al.
Publicado: (2020)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles
por: Bayik, Defne, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8t0lq9vhnf2bggmec8sse6uu5n